TFF PharmaceuticalsTFFP
13F holders, Q1 2024 (March 31)19holders
1famous investor
$6.05avg. 13F price*
At the end of Q1 2024, 19 institutions reported holding TFF Pharmaceuticals Inc. (TFFP) in their 13F filings. The largest holders were Carlson Capital, L.P. ($1.2M), DRW Securities, LLC ($242K) and Westside Investment Management, Inc. ($237K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- TFF Pharmaceuticals Inc.
- CUSIP
- 87241J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 5 | $215K |
Ownership 19 holders
| Carlson Capital, L.P. | 0.10% | No change | 193,960 | $1.2M |
| DRW Securities, LLC | 0.01% | No change | 40,000 | $242K |
| Westside Investment Management, Inc. | 0.06% | Add +382.1% | 39,225 | $237K |
| Vanguard Group Inc. | 0.00% | Add +2.6% | 34,743 | $210K |
| Geode Capital Management, LLC | 0.00% | Add +10.3% | 17,343 | $107K |
| Renaissance Technologies | 0.00% | Add +14.8% | 13,198 | $80K |
| BlackRock Inc. | 0.00% | Reduce -8.5% | 7,799 | $47K |
| UBS Group AG | 0.00% | Reduce -37.8% | 1,127 | $7K |
| University of Texas/Texas Am Investment Management Co. | 0.00% | Reduce -50.0% | 882 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -63.4% | 502 | $3K |
| Royal Bank of Canada | 0.00% | Add +57.6% | 487 | $3K |
| NFSG Corp | 0.00% | Reduce -67.9% | 434 | $3K |
| Gen-Wealth Partners Inc | 0.00% | — | 100 | $604 |
| Wells Fargo & Company | 0.00% | Add +1.3% | 78 | $471 |
| HM Payson & Co. | 0.00% | No change | 60 | $363 |
| Osaic Holdings, Inc. | 0.00% | No change | 40 | $241 |
| Bank of America Corp. | 0.00% | Reduce -62.0% | 35 | $211 |
| Morgan Stanley | 0.00% | No change | 32 | $193 |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.5% | 5 | $31 |
"% of holder's portfolio" is TFFP's weight in each manager's 13F, not the share of TFF Pharmaceuticals Inc. the manager owns.